429 related articles for article (PubMed ID: 25779597)
1. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.
Yeh JM; Hur C; Ward Z; Schrag D; Goldie SJ
Gut; 2016 Apr; 65(4):563-74. PubMed ID: 25779597
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic screening for gastric cancer.
Dan YY; So JB; Yeoh KG
Clin Gastroenterol Hepatol; 2006 Jun; 4(6):709-16. PubMed ID: 16765306
[TBL] [Abstract][Full Text] [Related]
3. Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter pylori Eradication.
Kowada A
Dig Dis Sci; 2021 Dec; 66(12):4220-4226. PubMed ID: 33417196
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of
Kowada A
Scand J Gastroenterol; 2019 Jun; 54(6):685-689. PubMed ID: 31190581
[No Abstract] [Full Text] [Related]
5. Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer.
Lee YC; Lin JT; Wu HM; Liu TY; Yen MF; Chiu HM; Wang HP; Wu MS; Hsiu-Hsi Chen T
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):875-85. PubMed ID: 17507609
[TBL] [Abstract][Full Text] [Related]
6. Contribution of H. pylori and smoking trends to US incidence of intestinal-type noncardia gastric adenocarcinoma: a microsimulation model.
Yeh JM; Hur C; Schrag D; Kuntz KM; Ezzati M; Stout N; Ward Z; Goldie SJ
PLoS Med; 2013; 10(5):e1001451. PubMed ID: 23700390
[TBL] [Abstract][Full Text] [Related]
7. A Population-Based Helicobacter pylori Eradication Strategy Is More Cost-Effective than Endoscopic Screening.
Kowada A
Dig Dis Sci; 2023 May; 68(5):1735-1746. PubMed ID: 36565366
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese.
Xie F; Luo N; Blackhouse G; Goeree R; Lee HP
Int J Technol Assess Health Care; 2008; 24(1):87-95. PubMed ID: 18218173
[TBL] [Abstract][Full Text] [Related]
9. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials.
Parsonnet J; Harris RA; Hack HM; Owens DK
Lancet; 1996 Jul; 348(9021):150-4. PubMed ID: 8684154
[TBL] [Abstract][Full Text] [Related]
10. Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada.
Xie F; O'Reilly D; Ferrusi IL; Blackhouse G; Bowen JM; Tarride JE; Goeree R
J Am Coll Radiol; 2009 May; 6(5):317-23. PubMed ID: 19394572
[TBL] [Abstract][Full Text] [Related]
11. Effect of Helicobacter pylori Eradication Therapy on the Incidence of Noncardia Gastric Adenocarcinoma in a Large Diverse Population in the United States.
Li D; Jiang SF; Lei NY; Shah SC; Corley DA
Gastroenterology; 2023 Aug; 165(2):391-401.e2. PubMed ID: 37142201
[TBL] [Abstract][Full Text] [Related]
12. Screening for gastric cancer in Western countries.
Lansdorp-Vogelaar I; Kuipers EJ
Gut; 2016 Apr; 65(4):543-4. PubMed ID: 26611232
[No Abstract] [Full Text] [Related]
13. Cost-effectiveness of endoscopic surveillance of gastric ulcers to improve survival.
Yeh JM; Ho W; Hur C
Gastrointest Endosc; 2010 Jul; 72(1):33-43. PubMed ID: 20430384
[TBL] [Abstract][Full Text] [Related]
14. Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis.
Gupta N; Bansal A; Wani SB; Gaddam S; Rastogi A; Sharma P
Gastrointest Endosc; 2011 Sep; 74(3):610-624.e2. PubMed ID: 21741639
[TBL] [Abstract][Full Text] [Related]
15. Cost-benefit of serum pepsinogen screening for gastric adenocarcinoma in the Mexican population.
Enríquez-Sánchez LB; Gallegos-Portillo LG; Camarillo-Cisneros J; Cisneros-Castolo M; Montelongo-Santiesteban JJ; Aguirre-Baca DA; Pérez-Echavarría AI; Contreras-Pacheco AE
Rev Gastroenterol Mex (Engl Ed); 2022; 87(3):285-291. PubMed ID: 34794924
[TBL] [Abstract][Full Text] [Related]
16. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of combined serum anti-Helicobacter pylori IgG antibody and serum pepsinogen concentrations for screening for gastric cancer risk in Japan.
Saito S; Azumi M; Muneoka Y; Nishino K; Ishikawa T; Sato Y; Terai S; Akazawa K
Eur J Health Econ; 2018 May; 19(4):545-555. PubMed ID: 28550494
[TBL] [Abstract][Full Text] [Related]
18. Both family-based Helicobacter pylori infection control and management strategy and screen-and-treat strategy are cost-effective for gastric cancer prevention.
Ma J; Yu M; Shao QQ; Yu XC; Zhang C; Zhao JB; Yuan L; Qi YB; Hu RB; Wei PR; Xiao W; Chen Q; Jia BL; Chen CL; Lu H; Ding SZ
Helicobacter; 2022 Aug; 27(4):e12911. PubMed ID: 35706404
[TBL] [Abstract][Full Text] [Related]
19. Multicentric randomised study of
Leja M; Park JY; Murillo R; Liepniece-Karele I; Isajevs S; Kikuste I; Rudzite D; Krike P; Parshutin S; Polaka I; Kirsners A; Santare D; Folkmanis V; Daugule I; Plummer M; Herrero R
BMJ Open; 2017 Aug; 7(8):e016999. PubMed ID: 28801429
[TBL] [Abstract][Full Text] [Related]
20. Review article: the epidemiology and prevention of gastric cancer.
Fock KM
Aliment Pharmacol Ther; 2014 Aug; 40(3):250-60. PubMed ID: 24912650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
